CRON - Cronos Group Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cronos Group Inc.

720 King Street West
Suite 320
Toronto, ON M5V 2T3

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees631

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael Ryan GorensteinChairman, Pres & CEO333.57kN/A1987
Mr. Jerry Filomena BarbatoChief Financial Officer299.63kN/A1976
Ms. Xiuming ShumExec. VP of Legal and Regulatory Affairs & Corp. Sec.190.18kN/A1986
Mr. Robert Steven RosenheckChief Exec. Officer of Redwood Wellness, LLC80.82kN/A1967
Mr. Eric KleinHead of MarketingN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations (“MMPR”). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in in Toronto, Canada.

Corporate Governance

Cronos Group Inc.’s ISS Governance QualityScore as of December 5, 2019 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.